Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 3
1988 6
1989 3
1990 4
1991 2
1992 6
1993 1
1994 4
1995 3
1996 3
1997 4
1998 3
1999 1
2000 1
2001 2
2002 5
2003 7
2004 8
2005 7
2006 15
2007 14
2008 20
2009 18
2010 19
2011 15
2012 10
2013 20
2014 18
2015 5
2016 8
2017 9
2018 10
2019 8
2020 4
2021 8
2022 11
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

267 results

Results by year

Filters applied: . Clear all
Page 1
Mitochondria dysfunction in circulating tumor cells.
Agnoletto C, Volinia S. Agnoletto C, et al. Among authors: volinia s. Front Oncol. 2022 Aug 4;12:947479. doi: 10.3389/fonc.2022.947479. eCollection 2022. Front Oncol. 2022. PMID: 35992829 Free PMC article. Review.
Predictive and Prognostic Value of Non-Coding RNA in Breast Cancer.
Sobhani N, Chahwan R, Roudi R, Morris R, Volinia S, Chai D, D'Angelo A, Generali D. Sobhani N, et al. Among authors: volinia s. Cancers (Basel). 2022 Jun 15;14(12):2952. doi: 10.3390/cancers14122952. Cancers (Basel). 2022. PMID: 35740618 Free PMC article. Review.
MicroRNA expression signatures in solid malignancies.
Galasso M, Sandhu SK, Volinia S. Galasso M, et al. Among authors: volinia s. Cancer J. 2012 May-Jun;18(3):238-43. doi: 10.1097/PPO.0b013e318258b5f4. Cancer J. 2012. PMID: 22647360 Review.
Retraction Note: EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers.
Garofalo M, Romano G, Di Leva G, Nuovo G, Jeon YJ, Ngankeu A, Sun J, Lovat F, Alder H, Condorelli G, Engelman JA, Ono M, Rho JK, Cascione L, Volinia S, Nephew KP, Croce CM. Garofalo M, et al. Among authors: volinia s. Nat Med. 2022 Nov;28(11):2436. doi: 10.1038/s41591-022-02044-2. Nat Med. 2022. PMID: 36195688 Free PMC article. No abstract available.
Retraction Notice to: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development.
Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R, Zhou W, Benson DM, Hofmainster C, Alder H, Garofalo M, Di Leva G, Volinia S, Lin HJ, Perrotti D, Kuehl M, Aqeilan RI, Palumbo A, Croce CM. Pichiorri F, et al. Among authors: volinia s. Cancer Cell. 2022 Nov 14;40(11):1441. doi: 10.1016/j.ccell.2022.10.006. Epub 2022 Oct 27. Cancer Cell. 2022. PMID: 36306793 Free PMC article. No abstract available.
The Network of Non-coding RNAs in Cancer Drug Resistance.
Corrà F, Agnoletto C, Minotti L, Baldassari F, Volinia S. Corrà F, et al. Among authors: volinia s. Front Oncol. 2018 Aug 29;8:327. doi: 10.3389/fonc.2018.00327. eCollection 2018. Front Oncol. 2018. PMID: 30211115 Free PMC article. Review.
Next generation analysis of breast cancer genomes for precision medicine.
Previati M, Manfrini M, Galasso M, Zerbinati C, Palatini J, Gasparini P, Volinia S. Previati M, et al. Among authors: volinia s. Cancer Lett. 2013 Oct 1;339(1):1-7. doi: 10.1016/j.canlet.2013.07.018. Epub 2013 Jul 20. Cancer Lett. 2013. PMID: 23879964 Review.
267 results